iGMDRD664

Canonical SMILES: CCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCCC4CCO

InChI: InChI=1S/C21H28N6O2/c1-2-17-14-23-27-19(22-13-16-6-5-9-25(29)15-16)12-20(24-21(17)27)26-10-4-3-7-18(26)8-11-28/h5-6,9,12,14-15,18,22,28H,2-4,7-8,10-11,13H2,1H3/t18-/m0/s1

InChI Key: PIMQWRZWLQKKBJ-SFHVURJKSA-N

Loading, please wait...
Standard Name
CHEMBL
Pubchem CID
DRUGBANK ID
Drug Status
Drug Type
Standard NameDinaciclib
CHEMBLCHEMBL2103840
Pubchem CID46926400
DRUGBANK IDDB12021
Drug StatusAlone
Drug TypeSmall Molecule

Drug-model tissue-cancer distribution: Bubble Plot

BREAStissue: BREAS cancer: BREAST model num: 0BREASTtissue: BREAST cancer: undefined model num: 2undefinetissue: undefine cancer: undefined model num: 0undefinedtissue: undefined cancer: PANCAN model num: 10OVARtissue: OVAR cancer: OVARY model num: 0OVARYtissue: OVARY cancer: Serous Ovarian Cancer (SOC) model num: 1

Drug-gene pathway enrichments

11reactome: Signal Transduction5reactome: Gene expression (Transcription)5reactome: RNA Polymerase II Transcription5reactome: Generic Transcription Pathway4reactome: Disease4reactome: Signaling by Receptor Tyrosine Kinases4wikipathways: Notch Signaling Pathway4kegg: Pathways in cancer - Homo sapiens (human)3wikipathways: PI3K-Akt Signaling Pathway3wikipathways: Signaling Pathways in Glioblastoma

Drug-gene GO enrichments

12CC: nucleus10CC: nucleoplasm9MF: protein binding8MF: protein tyrosine kinase activity8CC: cytoplasm7CC: plasma membrane7CC: cytosol6BP: positive regulation of transcription by RNA polymerase II6MF: RNA polymerase II transcription factor activity, sequence-specific DNA binding5BP: mismatch repair

Drug-Gene: Aster Plot


Loading, please wait...
Gene ID
Gene Name
Model Num.
4854 NOTCH3 1
7514 XPO1 1
2956 MSH6 1
2625 GATA3 1
Showing 1 to 4 of 8 rows

Gene in drug-gene network: Network Plot

SMAD1SMAD1selumetinib in BRAF mutant tumorsselumetinib in BRAF mutant tumorsBMS-754807BMS-754807MST-312MST-312PX 12PX 12tipifarnib-P2tipifarnib-P2BMS-536924BMS-536924NeratinibNeratinibcytochalasin.Bcytochalasin.BPIK-75PIK-75AZD-1775AZD-1775ML162ML162ceruleninceruleninFedratinibFedratinibAACOCF3AACOCF3(-)-gallocatechin-3-O-gallate(-)-gallocatechin-3-O-gallateKDRKDRBI-2536BI-2536GW-843682XGW-843682XPaclitaxelPaclitaxelGSK-461364GSK-461364XL-880XL-880PF 184PF 184XPO1XPO1SN-38SN-38salermidesalermideneopeltolideneopeltolideleucascandrolide Aleucascandrolide ANSC141540NSC141540VX-680VX-680Compound 10b [PMID: 11504634]Compound 10b [PMID: 11504634]triptolidetriptolideteniposideteniposideGemcitabineGemcitabinePAC-1PAC-1SirolimusSirolimusNOTCH3NOTCH3IdarubicinIdarubicinquinoclaminequinoclamineisoevodiamineisoevodiaminenakiterpiosinnakiterpiosinLY 2183240LY 2183240Nsc 632839Nsc 632839zebularinezebularineFQI-2FQI-2MSH6MSH6Aromatase InhibitorAromatase InhibitorGATA3GATA3GefitnibGefitnibcetuximabcetuximabGW-405833GW-405833BIX01294BIX01294NSC95397NSC95397DC-45-A2DC-45-A2DacomitinibDacomitinibAfatnibAfatnibirreversible EGFR TKIsirreversible EGFR TKIsErlotinibErlotinibPanitumumabPanitumumabEGFR TKIsEGFR TKIsOsimertinibOsimertinibHSP90 inhibitorsHSP90 inhibitorspevonedistatpevonedistatMEK inhibitors (alone or in combination)MEK inhibitors (alone or in combination)nutlin 3nutlin 3EGFREGFRBX-795BX-795DactolisibDactolisibCompound.1541ACompound.1541ACompound 110Compound 110OSW-1OSW-1BRD7137BRD7137CCNE1CCNE1DinaciclibDinaciclib

Models in Dinaciclib

Model
Level
Reference ID
Tissue
Cancer
Drug
Clinical Response
Source
EXP(GATA3) protein MCLP BREAST undefined dinaciclib sensitivity in vitro
EXP(JAGGED1) protein MCLP BREAST undefined dinaciclib resistance in vitro
EXP(EGFR) protein MCLP undefined PANCAN dinaciclib sensitivity in vitro
EXP(HER3_pY1289) protein MCLP undefined PANCAN dinaciclib sensitivity in vitro
EXP(SMAD1) protein MCLP undefined PANCAN dinaciclib resistance in vitro
EXP(VEGFR2) protein MCLP undefined PANCAN dinaciclib sensitivity in vitro
EXP(TRANSGLUTAMINASE) protein MCLP undefined PANCAN dinaciclib sensitivity in vitro
EXP(1433BETA) protein MCLP undefined PANCAN dinaciclib sensitivity in vitro
EXP(CMET) protein MCLP undefined PANCAN dinaciclib sensitivity in vitro
EXP(MSH6) protein MCLP undefined PANCAN dinaciclib resistance in vitro
Showing 1 to 10 of 13 rows rows per page

​​​​

SITE
DATATYPES
CLASSFICATION
Map

Copyright © 2018 Modellab | All Rights Reserved

Disclaimer: iGMDR is intended for research purposes only. Its information cannot be used for emergencies or medical or professional advice.